본문 바로가기
KERD
논문KCI 등재

High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: Surgery, radiotherapy (RT), and chemotherapy have prolonged the survival of patients with anaplastic oligodendroglio ma. However, whether RT induces long-term toxicity remains unknown. We analyzed the relationship between the RT dose to the fornix and symptomatic radiation necrosis (SRN). Materials and Methods: A total of 67 patients treated between 2009 and 2019 were analyzed. SRN was defined according to the following three criteria: 1) radiographic findings, 2) symptoms attributable to the lesion, and 3) treatment resulting in symptom improvement. Various contours, including the fornix, were delineated. Univariate and multivariate analyses of the relationship between RT dose and SRN, as well as receiver operating characteristic curve analysis for cut-off values, were performed. Results: The most common location was the frontal lobe (n=40, 60%). Gross total resection was performed in 38 patients (57%), and 42 patients (63%) received procarbazine, lomustine, and vincristine chemotherapy. With a median follow-up of 42 months, the me dian overall and progression-free survival was 74 months. Sixteen patients (24%) developed SRN. In multivariate analysis, age and maximum dose to the fornix were associated with the development of SRN. The cut-off values for the maximum dose to the fornix and age were 59 Gy (equivalent dose delivered in 2 Gy fractions) and 46 years, respectively. The rate of SRN was higher in patients whose maximum dose to the fornix was >59 Gy (13% vs. 43%, p=0.005). Conclusion: The maximum dose to the fornix was a significant factor for SRN development. While fornix sparing may help main tain neurocognitive function, additional studies are needed.

Abstract

Purpose: Surgery, radiotherapy (RT), and chemotherapy have prolonged the survival of patients with anaplastic oligodendroglio ma. However, whether RT induces long-term toxicity remains unknown. We analyzed the relationship between the RT dose to the fornix and symptomatic radiation necrosis (SRN). Materials and Methods: A total of 67 patients treated between 2009 and 2019 were analyzed. SRN was defined according to the following three criteria: 1) radiographic findings, 2) symptoms attributable to the lesion, and 3) treatment resulting in symptom improvement. Various contours, including the fornix, were delineated. Univariate and multivariate analyses of the relationship between RT dose and SRN, as well as receiver operating characteristic curve analysis for cut-off values, were performed. Results: The most common location was the frontal lobe (n=40, 60%). Gross total resection was performed in 38 patients (57%), and 42 patients (63%) received procarbazine, lomustine, and vincristine chemotherapy. With a median follow-up of 42 months, the me dian overall and progression-free survival was 74 months. Sixteen patients (24%) developed SRN. In multivariate analysis, age and maximum dose to the fornix were associated with the development of SRN. The cut-off values for the maximum dose to the fornix and age were 59 Gy (equivalent dose delivered in 2 Gy fractions) and 46 years, respectively. The rate of SRN was higher in patients whose maximum dose to the fornix was >59 Gy (13% vs. 43%, p=0.005). Conclusion: The maximum dose to the fornix was a significant factor for SRN development. While fornix sparing may help main tain neurocognitive function, additional studies are needed.

참고문헌 (38)

  1. Engelhard HH, "Oligodendroglioma and anaplastic oligodendroglioma : clinical features, treatment, and prognosis", Surg Neurol, 60, pp.443~456 (2003)
  2. Louis DN, "The 2007 WHO classification of tumours of the central nervous system", Acta Neuropathol, 114, pp.97~109 (2007)
  3. Ostrom QT, "CBTRUS statistical report : primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016", Neuro Oncol, 21(Suppl 5), pp.v1~v100 (2019)
  4. Roux FX, "Cerebral oligodendrogliomas in adults and children. Current data and perspectives", Neurochirurgie, 51(3-4Pt 2), pp.410~414 (2005)
  5. van den Bent MJ, "Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma : long-term follow-up of EORTC brain tumor group study 26951", J Clin Oncol, 31, pp.344~350 (2013)
  6. van den Bent MJ, "Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features", Cancer, 97, pp.1276~1284 (2003)
  7. Sundgren PC, "Brain irradiation : effects on normal brain parenchyma and radiation injury", Neuroimaging Clin N Am, 19, pp.657~668 (2009)
  8. Brown PD, "Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases : phase III trial NRG oncology CC001", J Clin Oncol, 38, pp.1019~1029 (2020)
  9. Vees H, "Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer. A multicenter phase 2 trial(SAKK 15", 12), 2020, pp.107, 279~287
  10. Sundgren P, "Correlation of magnetic resonance imaging morphologic abnormalities, magnetic resonance spectroscopy and radiation treatment dose-volumes in histologically proven cerebral radiation necrosis", Proceedings of the ASNR 47th Annual Meeting & NER Foundation Symposium 2009, pp.395~ (2009), ASNR
  11. Nazem-Zadeh MR, "Radiation therapy effects on white matter fiber tracts of the limbic circuit", Med Phys, 39, pp.5603~5613 (2012)
  12. Ghia A, "Distribution of brain metastases in relation to the hippocampus : implications for neurocognitive functional preservation", Int J Radiat Oncol Biol Phys, 68, pp.971~977 (2007)
  13. McGirt MJ, "Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas", Neurosurgery, 63, pp.700~707 (2008)
  14. Senova S, "Anatomy and function of the fornix in the context of its potential as a therapeutic target", J Neurol Neurosurg Psychiatry, 91, pp.547~559 (2020)
  15. Martin AM, "Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation", JAMA Oncol, 4, pp.1123~1124 (2018)
  16. Mullins ME, "Radiation necrosis versus glioma recurrence : conventional MR imaging clues to diagnosis", AJNR Am J Neuroradiol, 26, pp.1967~1972 (2005)
  17. Xu JL, "Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging", Neuroradiology, 52, pp.1193~1199 (2010)
  18. Xu JL, "Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging", J Med Imaging Radiat Oncol, 55, pp.587~594 (2011)
  19. Kim YH, "Differentiating radiation necrosis from tumor recurrence in high-grade gliomas : assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI", Clin Neurol Neurosurg, 112, pp.758~765 (2010)
  20. Park YW, "Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation", Sci Rep, 11, pp.2913~ (2021)
  21. Peng L, "Distinguishing true progression from radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics", Int J Radiat Oncol Biol Phys, 102, pp.1236~1243 (2018)
  22. Zhang Z, "A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images", Eur Radiol, 28, pp.2255~2263 (2018)
  23. Ma TM, "Volume effects in radiosurgical spinal cord dose tolerance : how small is too small?", J Radiat Oncol, 8, pp.53~61 (2019)
  24. Shaw E, "Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma : initial report of a North Central Cancer Treatment Group", Radiation Therapy Oncology Group, J Clin Oncol, pp.2002, 20[DOI]
  25. Gerosa M, "Gamma knife radiosurgery for brain metastases : a primary therapeutic option", J Neurosurg, 97(5 Suppl), pp.515~524 (2002)
  26. Kim JW, "Fractionated stereotactic gamma knife radiosurgery for large brain metastases : a retrospective, single center study", PLoS One, 11, pp.e0163304~ (2016)
  27. Iorio-Morin C, "Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases", J Neurooncol, 145, pp.551~559 (2019)
  28. Minniti G, "Single-fraction versus multifraction(3×9 Gy)stereotactic radiosurgery for large(>2 cm)brain metastases : a comparative analysis of local control and risk of radiation-induced brain necrosis", Int J Radiat Oncol Biol Phys, 95, pp.1142~1148 (2016)
  29. Flickinger JC, "Complications from arteriovenous malformation radiosurgery : multivariate analysis and risk modeling", Int J Radiat Oncol Biol Phys, 38, pp.485~490 (1997)
  30. Flickinger JC, "Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients", Int J Radiat Oncol Biol Phys, 46, pp.1143~1148 (2000)
  31. Shaw E, "Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases : final report of RTOG protocol 90-05", Int J Radiat Oncol Biol Phys, 47, pp.291~298 (2000)
  32. Carrie C, "Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma : long-term results of MSFOP 98", J Clin Oncol, 27, pp.1879~1883 (2009)
  33. Jalali R, "Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy", Int J Radiat Oncol Biol Phys, 77, pp.974~979 (2010)
  34. Reimers TS, "Cognitive deficits in long-term survivors of childhood brain tumors : identification of predictive factors", Med Pediatr Oncol, 40, pp.26~34 (2003)
  35. Merchant TE, "Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma", Int J Radiat Oncol Biol Phys, 90, pp.554~561 (2014)
  36. Jacola LM, "The relationship between working memory and cerebral white matter volume in survivors of childhood brain tumors treated with conformal radiation therapy", J Neurooncol, 119, pp.197~205 (2014)
  37. Makola M, "Long-term effects of radiation therapy on white matter of the corpus callosum : a diffusion tensor imaging study in children", Pediatr Radiol, 47, pp.1809~1816 (2017)
  38. Mehta P, "Sparing the hippocampus and the hypothalamic-pituitary region during whole brain radiotherapy : a volumetric modulated arc therapy planning study", BMC Cancer, 20, pp.610~ (2020)

관련 논문AI추천

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma공두식, 남도현, 설호준, 이정일, 임도훈, 최정원, Nalee Kim연세대학교의과대학 · Yonsei Medical Journal2023 · 제64권 제2호Risk Factors for Cognitive Impairment in High-Grade Glioma Patients Treated with Postoperative RadiochemotherapyFei Qi, Fengxia Xiao, Qiang Wang, Xiaopeng Song, Yonghua Yu대한암학회 · Cancer Research and Treatment2020 · 제52권 제2호Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report김세훈, 김주호, 김준원, 박광우, 서양권, 서창옥, 이규성, 장종희, 장지석, 조재호, 차지혜연세대학교의과대학 · Yonsei Medical Journal2014 · 제55권 제1호The Role of Radiotherapy in the Treatment of Newly Diagnosed Supratentorial Low-grade Oligodendrogliomas: Comparative Analysis with Immediate Radiotherapy versus Surgery Alone강현철, 김일한, 김진호, 엄근용, 정희원대한암학회 · Cancer Research and Treatment2009 · 제41권 제3호Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival서창옥, 안성수, 이정심, 장종희연세대학교의과대학 · Yonsei Medical Journal2018 · 제59권 제2호Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance강대규, 김성환, 김영경, 이종훈대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호

이 간행물의 다른 논문 (6건)